Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
Healthy Males and Females, Ages 18-55
8484-036 3
Back To Current StudiesHealthy Males and Females, Ages 18-55
Study Number
8484-036Group
3Gender
bothAge
18 - 55Location
Madison, WisconsinCompensation
$6,566Study Dates
Jul. 23 - Aug. 21, 2023Additional Information
This is a research study for an investigational drug being developed for the treatment of HIV-1 infection (Human Immunodeficiency Virus-1).
The purpose of this study is to evaluate the safety and tolerability (side effects) of the study drug at gradually increasing dose levels. The study will also measure how much of the study drug and its breakdown products gets into the bloodstream (and certain kinds of blood cells), and how long it takes the body to get rid of it. In addition, this study will compare how much of the study drug gets into the bloodstream between 2 different forms of the study drug (tablet and a liquid solution drink).
Recruiting for:
- Healthy Males and Females, age 18-55
- Body Mass Index between 18.5-32
- Study involves 1 stay of 14 nights and 2 follow-ups
- Compensation up to $6,566 may be provided for time and participation
- Receive up to $200 per qualified referral
Details
Check-In: July 23
Check-Out: August 6
Outpatient Visits: August 1, August 21